Option Care Health, Inc. (OPCH)
NASDAQ: OPCH · Real-Time Price · USD
19.52
-0.43 (-2.16%)
At close: May 15, 2026, 4:00 PM EDT
19.58
+0.06 (0.31%)
After-hours: May 15, 2026, 7:54 PM EDT
Option Care Health Stock Forecast
Stock Price Forecast
The 9 analysts that cover Option Care Health stock have a consensus rating of "Strong Buy" and an average price target of $33.78, which forecasts a 73.05% increase in the stock price over the next year. The lowest target is $23 and the highest is $40.
Price Target: $33.78 (+73.05%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Option Care Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $38 → $28 | Buy | Maintains | $38 → $28 | +43.44% | May 6, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $40 → $33 | Buy | Maintains | $40 → $33 | +69.06% | May 4, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $42 → $32 | Buy | Maintains | $42 → $32 | +63.93% | May 1, 2026 |
| UBS | UBS | Strong Buy Maintains $45 → $39 | Strong Buy | Maintains | $45 → $39 | +99.80% | May 1, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $37 → $23 | Hold | Maintains | $37 → $23 | +17.83% | May 1, 2026 |
Financial Forecast
Revenue This Year
5.88B
from 5.65B
Increased by 4.06%
Revenue Next Year
6.35B
from 5.88B
Increased by 7.93%
EPS This Year
1.89
from 1.27
Increased by 48.66%
EPS Next Year
2.12
from 1.89
Increased by 12.38%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 6.2B | 6.8B | ||
| Avg | 5.9B | 6.3B | ||
| Low | 5.6B | 5.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 10.4% | 15.9% | ||
| Avg | 4.1% | 7.9% | ||
| Low | -1.5% | 0.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 1.98 | 2.27 | ||
| Avg | 1.89 | 2.12 | ||
| Low | 1.77 | 1.94 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 56.3% | 20.1% | ||
| Avg | 48.7% | 12.4% | ||
| Low | 39.7% | 2.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.